Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-09-13 2023-09-23 204210
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-09-07 2023-09-23 203858
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-08-16 2023-08-28 201903
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-07-21 2023-08-28 199441
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-08-08 2023-08-18 201413
BIPHENTIN 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-07-07 2023-07-15 197815
BIPHENTIN 10MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-28 2023-07-12 196775

Showing 21 to 30 of 198

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPHENIDATE 20MG TABLET Discontinued 2019-04-10 2019-04-11 81139

Showing 11 to 11 of 11